MedRhythms, Inc. recently featured in the Rolling Stone

This innovative Maine company recently announced a new partnership with Universal Music Group, the world's largest record label. 

With the partnership, patients will have access to a vast catalogue of music and diverse artists, which will elevate the #PatientExperience with the company's prescription music digital therapeutic.

“Everybody can relate to the fact that music evokes emotions and memories, and that’s the social science of music, but what MedRhythms is doing is shifting that paradigm to look at music purely through the lens of neuroscience. Music has a profound impact on our brains, objectively. Regardless of age, culture, ability or disability, almost everybody’s brain responds the same way to music. At a high level, when we as humans are passively listening to music that we like, it engages parts of our brain responsible for movement, language, and attention. There’s no other stimulus on Earth that engages our brain like music does.”

- @Brian Harris 

Read more

About Maine Venture Fund

Maine Venture Fund invests in dynamic businesses that have the potential for significant growth and impact in Maine. For more information, visit maineventurefund.com. 

Inquiries:
Terri Wark
Maine Venture Fund
(207) 924.3800
terri@maineventurefund.com